In the hyper-competitive pharmaceutical market, great products, great services and even great bottom-line results aren’t always enough to build a lasting brand. The most innovative companies in the industry must often take extra steps.
QIAGEN, a billion-dollar global company that provides sample and assay technologies used in medical practice, as well as biological and pharmaceutical research and development, was well-known and extremely respected by scientists around the world. But the company faced a broader challenge to also raise its profile in the US market, especially with business media and investors.
LEVICK launched a comprehensive communications and government relations program that leveraged current news topics, such as HPV testing. Even pop culture provided grist for the mill since QIAGEN equipment often appears on television programs like CSI.
The aggressive initiative reinvigorated the company’s public presence and reinforced the quality and breadth of its products while helping pave the way for a comprehensive restructuring program focused on high-growth areas.
- Case Study
- FIGHTING XENOPHOBIA WITH COMMUNITY ACTIVISM
- ELITE SCHOOL UNDER FIRE
- A Digital Solution to a Middle East Problem
- MAINTAINING SUMMER FUN AMID A THEME PARK BANKRUPTCY
- ASSIGNING RESPONSIBILITY FOR A FATAL HELICOPTER CRASH
- MAKING A CASE FOR THOSE WRONGLY DETAINED IN GUANTANAMO BAY
- EXPOSING THE FLAWS OF AN EXPERT WITNESS
- TROLL STIGMA
- WINNING DUBAI THE TRUST OF THE WEST
- A SOVEREIGN NATION
- A WALL STREET TITAN TEETERS ON THE BRINK
- AFTER A MEGA DATA BREACH, MONUMENTAL LEADERSHIP
- BLOCKING A BANK MERGER HALFWAY ACROSS THE WORLD
- BUILDING THE BRAND
- CHINA CHALLENGE
- CONGRESS PROBES A ROYAL FAMILY BANK
- GAO PROTEST
- GOD & GUNS: A DANGEROUS MIX FOR ONE DEFENSE CONTRACTOR
- HELPING AN AIRLINE PREPARE FOR THE WORST
- Case Study